Assessment of hyperphagia in Prader-Willi syndrome
- PMID: 17636101
- DOI: 10.1038/oby.2007.216
Assessment of hyperphagia in Prader-Willi syndrome
Abstract
Objective: Prader-Willi syndrome (PWS), the leading known genetic cause of obesity, is characterized by intellectual disabilities, maladaptive and compulsive behaviors, and hyperphagia. Although complications of obesity resulting from hyperphagia are the leading cause of death in PWS, quantifying this drive for food has long been an unmet research need. This study provides factor-analytic and within-syndrome analyses of a new measure of hyperphagia in PWS.
Research methods and procedure: A 13-item informant measure, the Hyperphagia Questionnaire, was developed and administered to the parents of 153 persons with PWS, 4 to 51 years of age. The intelligence quotients, genetic subtypes of PWS, and BMIs of offspring were obtained, as were measures of their non-food problem behaviors.
Results: Factor analyses with varimax rotation produced three statistically and conceptually robust factors that accounted for 59% of the variance: Hyperphagic Behaviors, Drive, and Severity. Hyperphagic Behavior increased with age, whereas Drive remained stable, and Severity dipped in older adults. Hyperphagic Drive and Severity were positively correlated with non-food behavior problems, and Hyperphagic Drive differentiated the 36% of participants with extreme obesity from those who had overweight/obese (48%) or healthy (16%) BMI classifications.
Discussion: The Hyperphagia Questionnaire is a robust tool for relating breakthroughs in the neurobiology of hyperphagia to in vivo food-seeking behavior and for examining the psychological and developmental correlates of hyperphagia in PWS. The Hyperphagia Questionnaire also offers a nuanced, real-life outcome measure for future clinical trials aimed at curbing the life-threatening drive for food in PWS.
Similar articles
-
Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-Like" patients.J Am Acad Child Adolesc Psychiatry. 1999 Mar;38(3):329-34. doi: 10.1097/00004583-199903000-00021. J Am Acad Child Adolesc Psychiatry. 1999. PMID: 10087695
-
Compulsive behavior in Prader-Willi syndrome: examining severity in early childhood.Res Dev Disabil. 2006 Mar-Apr;27(2):190-202. doi: 10.1016/j.ridd.2005.01.002. Epub 2005 Jun 13. Res Dev Disabil. 2006. PMID: 15950435
-
Cognitive profile in a large French cohort of adults with Prader-Willi syndrome: differences between genotypes.J Intellect Disabil Res. 2010 Mar;54(3):204-15. doi: 10.1111/j.1365-2788.2010.01251.x. Epub 2010 Feb 2. J Intellect Disabil Res. 2010. PMID: 20136683
-
[Care continuity for patients with Prader-Willi syndrome during transition from childhood to adulthood].Nihon Rinsho. 2010 Jan;68(1):141-4. Nihon Rinsho. 2010. PMID: 20077807 Review. Japanese.
-
Prader-Willi syndrome: an update and review for the primary pediatrician.Clin Pediatr (Phila). 2007 Sep;46(7):580-91. doi: 10.1177/0009922807299314. Epub 2007 May 23. Clin Pediatr (Phila). 2007. PMID: 17522286 Review.
Cited by
-
Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study.J Pediatr Endocrinol Metab. 2014 Jan;27(1-2):23-9. doi: 10.1515/jpem-2013-0116. J Pediatr Endocrinol Metab. 2014. PMID: 23893676 Free PMC article.
-
Approach to the Patient With Hypothalamic Obesity.J Clin Endocrinol Metab. 2023 Apr 13;108(5):1236-1242. doi: 10.1210/clinem/dgac678. J Clin Endocrinol Metab. 2023. PMID: 36413492 Free PMC article.
-
The Feasibility and Effectiveness of a Novel, On-Line Social Skills Intervention for Individuals With Prader-Willi Syndrome.Front Psychiatry. 2022 May 24;13:863999. doi: 10.3389/fpsyt.2022.863999. eCollection 2022. Front Psychiatry. 2022. PMID: 35693970 Free PMC article.
-
Food socialization of children with Prader-Willi syndrome: an interdisciplinary problematization.Front Nutr. 2023 Jun 6;10:1177348. doi: 10.3389/fnut.2023.1177348. eCollection 2023. Front Nutr. 2023. PMID: 37346908 Free PMC article.
-
Measuring Meaningful Benefit-Risk Tradeoffs to Promote Patient-Focused Drug Development in Prader-Willi Syndrome: A Discrete-Choice Experiment.MDM Policy Pract. 2021 Sep 2;6(2):23814683211039457. doi: 10.1177/23814683211039457. eCollection 2021 Jul-Dec. MDM Policy Pract. 2021. PMID: 34497876 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases